ACP5, a direct transcriptional target of FoxM1, promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma

Oncogene

Volumn 33, Issue 11, 2014, Pages 1395-1406

  Xia, L ^a   Huang, W ^a   Tian, D ^b   Chen, Z ^a   Zhang, L ^a   Li, Y ^c   Hu, H ^a   Liu, J ^a   Tang, G ^a   Dou, J ^a   Sha, S ^a   Xu, B ^a   Liu, C ^a   Ma, J ^a   Zhang, S ^a   Li, M ^a   Fan, D ^a   Nie, Y ^a   Wu, K ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Forkhead box M1; hepatocellular carcinoma; metastasis; tartrate resistant acid phosphatase 5; transcriptional regulation

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME 5; COMPLEMENTARY DNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FORKHEAD BOX M1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LUCIFERASE ASSAY; LUNG METASTASIS; MALE; METASTASIS; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SITE DIRECTED MUTAGENESIS; SURVIVAL; TRANSACTIVATION; TUMOR INVASION; TUMOR PROMOTION; UPREGULATION; WESTERN BLOTTING;

ACID PHOSPHATASE; ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; ISOENZYMES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS;

EID: 84896395981     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.90     Document Type: Article

References (34)

1. Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastro-enterol Hepatol 2010; 7: 448-458.
2. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008; 134: 1752-1763. (Pubitemid 351615415)
3. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365: 1118-1127.
4. Raychaudhuri P, Park HJ. FoxM1: a master regulator of tumor metastasis. Cancer Res 2011; 71: 4329-4333.
5. Bao B, Wang Z, Ali S, Kong D, Banerjee S, Ahmad A et al. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell pheno-type in pancreatic cancer cells. J Cell Biochem 2011; 112: 2296-2306.
6. Dai B, Kang SH, Gong W, Liu M, Aldape KD, Sawaya R et al. Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene 2007; 26: 6212-6219. (Pubitemid 47414378)
7. Wang IC, Chen YJ, Hughes DE, Ackerson T, Major ML, Kalinichenko VV et al. FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness. J Biol Chem 2008; 283: 20770-20778.
8. Wang Z, Banerjee S, Kong D, Li Y, Sarkar FH. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res 2007; 67: 8293-8300. (Pubitemid 47395167)
9. Huang C, Qiu Z, Wang L, Peng Z, Jia Z, Logsdon CD et al. A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis. Cancer Res 2012; 72: 655-665.
10. Park HJ, Gusarova G, Wang Z, Carr JR, Li J, Kim KH et al. Deregulation of FoxM1b leads to tumour metastasis. EMBO Mol Med 2011; 3: 21-34.
11. Wang X, Quail E, Hung NJ, Tan Y, Ye H, Costa RH. Increased levels of forkhead box M1B transcription factor in transgenic mouse hepatocytes prevent age-related proliferation defects in regenerating liver. Proc Natl Acad Sci USA 2001; 98: 11468-11473. (Pubitemid 32928752)
12. Wang X, Kiyokawa H, Dennewitz MB, Costa RH. The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc Natl Acad Sci USA 2002; 99: 16881-16886. (Pubitemid 36034067)
13. Kalinichenko VV, Major ML, Wang X, Petrovic V, Kuechle J, Yoder HM et al. Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev 2004; 18: 830-850. (Pubitemid 38480894)
14. Gusarova GA, Wang IC, Major ML, Kalinichenko VV, Ackerson T, Petrovic V et al. A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment. J Clin Invest 2007; 117: 99-111. (Pubitemid 46048457)
15. Calvisi DF, Pinna F, Ladu S, Pellegrino R, Simile MM, Frau M et al. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. Gut 2009; 58: 679-687.
16. Sun H, Teng M, Liu J, Jin D, Wu J, Yan D et al. FOXM1 expression predicts the prognosis in hepatocellular carcinoma patients after orthotopic liver transplantation combined with the Milan criteria. Cancer Lett 2011; 306: 214-222.
17. Xia L, Huang W, Tian D, Zhu H, Zhang Y, Hu H et al. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. J Hepatol 2012; 57: 600-612.
18. Xia L, Mo P, Huang W, Zhang L, Wang Y, Zhu H et al. The TNF-alpha/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis. Carcinogenesis 2012; 33: 2250-2259.
19. Halleen JM, Alatalo SL, Janckila AJ, Woitge HW, Seibel MJ, Vaananen HK. Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption. Clin Chem 2001; 47: 597-600. (Pubitemid 32222482)
20. Adams LM, Warburton MJ, Hayman AR. Human breast cancer cell lines and tissues express tartrate-resistant acid phosphatase (TRAP). Cell Biol Int 2007; 31: 191-195. (Pubitemid 46187104)
21. Honig A, Rieger L, Kapp M, Krockenberger M, Eck M, Dietl J et al. Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study. BMC Cancer 2006; 6: 199.
22. Capeller B, Caffier H, Sutterlin MW, Dietl J. Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer. Anticancer Res 2003; 23: 1011-1015. (Pubitemid 36750912)
23. Chao TY, Yu JC, Ku CH, Chen MM, Lee SH, Janckila AJ et al. Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients. Clin Cancer Res 2005; 11: 544-550. (Pubitemid 40116878)
24. Lyubimova NV, Pashkov MV, Tyulyandin SA, Gol'dberg VE, Kushlinskii NE. Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer. Bull Exp Biol Med 2004; 138: 77-79. (Pubitemid 39485461)
25. Wu YY, Janckila AJ, Ku CH, Yu CP, Yu JC, Lee SH et al. Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis. BMC Cancer 2010; 10: 158.
26. Zenger S, He W, Ek-Rylander B, Vassiliou D, Wedin R, Bauer H et al. Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease. Clin Exp Metastasis 2011; 28: 65-73.
27. Scott KL, Nogueira C, Heffernan TP, van Doorn R, Dhakal S, Hanna JA et al. Proinvasion metastasis drivers in early-stage melanoma are oncogenes. Cancer Cell 2011; 20: 92-103.
28. Laoukili J, Stahl M, Medema RH. FoxM1: at the crossroads of ageing and cancer. Biochim Biophys Acta 2007; 1775: 92-102. (Pubitemid 44881197)
29. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC. The role of focal-adhesion kinase in cancer-a new therapeutic opportunity. Nat Rev Cancer 2005; 5: 505-515. (Pubitemid 40942827)
30. Scott KL, Nogueira C, Heffernan TP, van Doorn R, Dhakal S, Hanna JA et al. Proinvasion metastasis drivers in early-stage melanoma are oncogenes. Cancer Cell 2011; 20: 92-103.
31. Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005; 6: 56-68. (Pubitemid 40064899)
32. Li Y, Tang ZY, Hou JX. Hepatocellular carcinoma: insight from animal models. Nat Rev Gastroenterol Hepatol 2012; 9: 32-43.
33. Xia L, Tian D, Huang W, Zhu H, Wang J, Zhang Y et al. Upregulation of IL-23 expression in patients with chronic hepatitis B is mediated by the HBx/ERK/NF-kappaB pathway. J Immunol 2012; 188: 753-764.
34. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48, 900 necropsies. Cancer 1954; 7: 462-503.